Amgen Portugal

Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Amgen Portugal

Portugal

amgen-logo.jpgAbout Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be the world’s largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Pioneering Medicines

Amgen‘s medicines treat serious illnesses. We have a presence in more than 50 countries worldwide and have reached millions of people in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. Our medicines typically address diseases for which the number of effective treatment options is limited, or they are medicines that provide a viable option to what is otherwise available.

Innovative Research

Understanding the fundamental biological mechanisms of human life is a defining feature of Amgen‘s discovery research efforts—and a major contributor to the development of Amgen‘s deep and broad pipeline of potential new medicines. Amgen‘s ‘biology first’ approach permits its scientists to first explore the complex molecular pathways of disease before determining what type of medicine, or modality, is most likely to deliver optimal efficacy and safety. As advances in human genetics continue to shed new light on the molecular roots of disease, Amgen subsidiary deCODE Genetics, a global leader in human genetics, is a powerful differentiator, greatly improving how we identify and validate human disease targets.

World-Class Manufacturing

The treatment of millions of seriously ill patients worldwide depends on the safe and reliable production of biologic medicines, which are administered by injection or intravenously. A worldwide leader in biologics manufacturing, Amgen has an outstanding track record of reliably delivering high-quality medicines to patients who need them. Significant skill, experience, vigilance and commitment are critical to help ensure the quality of a biologic medicine each time a new batch is made. At Amgen, robust quality control and a reliable supply of medicines for patients are every bit as important as scientific innovation.

Contact Information

http://www.amgen.pt/about/amgen_portugal.html

Amgen Biofarmacêutica, Lda.

Edifício Dª.Maria I (Q60), Piso 2 – A,
Quinta da Fonte
2770-229 Paço d’Arcos

Tel:  +351 214 220 550
Fax: +351 214 220 555

 


filterProfiles

Find a company:







Jobs from Indeed
LATEST ISSUE

DOWNLOAD


X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: